Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Current clinical trials of cilengitide, an alpha(v) antagonist in clinical development as an anticancer agent ONCOLOGY-NEW YORK Colevas, A. D., Scharf, O., Schoenfeldt, M. 2004; 18 (14): 1778-?
View details for Web of Science ID 000238212800012